Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SEAGEN INC.

(SGEN)
  Report
Delayed Nasdaq  -  04:00 2022-12-09 pm EST
124.00 USD   -0.99%
12/08Peripheral T-Cell Lymphomas Pipeline as Novel and Extensive 40+ Therapies Likely to Enter in the Treatment Domain
AQ
12/02Seagen to Highlight ADCETRIS Clinical Progress at the 2022 American Society of Hematology Annual Meeting
AQ
12/01Seagen to Highlight ADCETRIS« (brentuximab vedotin) Clinical Progress at the 2022 American Society of Hematology (ASH) Annual Meeting
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies